Winton Group’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-32,555
Closed -$461K 739
2024
Q1
$461K Buy
+32,555
New +$461K 0.03% 480